Phage Endolysin LysP108 Showed Promising Antibacterial Potential Against Methicillin-resistant Staphylococcus aureus

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 82 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Bacteriophage as a Potential Biotherapeutics to Combat Present-Day Crisis of Multi-Drug Resistant Pathogens

Article in Heliyon (September 2024)

Phage endolysins as new therapeutic options for multidrug resistant Staphylococcus aureus: an emerging antibiotic-free way to combat drug resistant infections

Article in Frontiers in Cellular and Infection Microbiology (June 2024)

LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms

Article in Microbial Cell Factories (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.